QR-Code

Unified model involving genomics, magnetic resonance imaging and prostate‐specific antigen density outperforms individual co‐variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer

Abstract Background Active surveillance (AS) is the reference standard treatment for the management of low risk prostate cancer (PCa). Accurate assessment of tumor aggressiveness guides recruitment to AS programs to avoid conservative treatment of intermediate and higher risk patients. Nevertheless,...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Alp Tuna Beksac, Parita Ratnani, Zachary Dovey, Sneha Parekh, Ugo Falagario, Reza Roshandel, Stanislaw Sobotka, Deepshikha Kewlani, Avery Davis, Rachel Weil, Hafis Bashorun, Ivan Jambor, Sara Lewis, Kenneth Haines, Ashutosh K. Tewari
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley 2022-03-01
Schriftenreihe:Cancer Reports
Schlagworte:
active surveillance
biomarker
genomic prostate score
multiparametric MRI
oncotype
prostate cancer
Online-Zugang:https://doi.org/10.1002/cnr2.1492
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge